Cello Group confident of achieving expectations in 2017
Cello Group's shares are up almost 2% after investors focused on the company's confidence in achieving expectations for 2017 over its swing to a full-year pre-tax loss in 2016
Cello Health
161.00p
13:59 11/08/20
FTSE AIM All-Share
753.12
16:50 25/04/24
Media
11,717.59
17:09 25/04/24
Investors liked Cello's comment that it had started 2017 with good levels of forward bookings and already secured a good level of new business wins.
"Following the recent fundraise to finance the acquisition of Defined Health, the group is in the process of expanding its global footprint," it said.
"The Board is confident that expectations for 2017 will be met," the pharmaceutical and consumer strategic marketing group said.
Pre-tax loss from continuing operations of £1.7m , from a profit of £5.0m. Revenue was up, hitting £165.3m, from £156.7m.
These were accompanied by a full-year dividend of 3.4p a share, up from 2.86p.
At 11:49 GMT, shares in AIM-listed Cello were up 1.68% to 121p each.